- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 413/00 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 413/00
Total number of patents in this class: 330
10-year publication summary
|
7
|
5
|
5
|
15
|
11
|
6
|
6
|
5
|
7
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4764 |
15 |
| Merck Sharp & Dohme LLC | 3738 |
13 |
| Merck Sharp & Dohme Corp. | 2184 |
10 |
| Boehringer Ingelheim International GmbH | 4485 |
10 |
| Janssen Pharmaceutica N.V. | 3160 |
10 |
| Merck Patent GmbH | 5739 |
8 |
| Novartis AG | 10175 |
7 |
| Glaxosmithkline LLC | 526 |
6 |
| Amgen Inc. | 4436 |
5 |
| Gilead Sciences, Inc. | 2242 |
5 |
| Intellikine LLC | 41 |
4 |
| Hoffmann-La Roche Inc. | 3825 |
3 |
| Syngenta Participations AG | 1492 |
3 |
| Allergan, Inc. | 2155 |
3 |
| Merck Sharp & Dohme B.V. | 938 |
3 |
| Rigel Pharmaceuticals, Inc. | 520 |
3 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 718 |
3 |
| Eisai R&D Management Co., Ltd. | 1164 |
3 |
| in The Bowl Animal Health, Inc. | 37 |
3 |
| The Regents of the University of California | 20842 |
2 |
| Other owners | 211 |